Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,949 total articles

Tandy Leather Factory Reports First Quarter 2026 Results

Tandy Leather Factory Reports First Quarter 2026 Results

Tandy Leather Factory reported a 3.2% increase in Q1 2026 revenues to $19.7 million and an operating income increase to $0.4 million from $0.3 million the previous year. However, net income fell sharply to $0.2 million compared to $11.6 million in Q1 2025, mainly due to the absence of one-time gains from the prior year's headquarters sale. Gross ma…

Fabrinet to Present at J.P. Morgan Conference

Fabrinet to Present at J.P. Morgan Conference

Fabrinet, a leader in advanced optical packaging and precision manufacturing services, announced that its management will present at the upcoming J.P. Morgan 2026 Global Technology, Media and Communications Conference in Boston. The presentation is scheduled for May 18, 2026, and will be webcast live. Fabrinet operates globally with engineering and…

Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Pharvaris N.V., a late-stage biopharmaceutical firm focused on developing oral bradykinin B2 receptor antagonists for hereditary and acquired angioedema, successfully closed an underwritten offering raising $132.3 million. The funds will support ongoing Phase 3 clinical trials and marketing authorization applications for their lead candidates, adva…

CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC

CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC

CG Oncology, Inc. will present first results from its CORE-008 Phase 2 trial assessing intravesical combination therapy for high-risk BCG-exposed and BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) at the American Urological Association (AUA) 2026 Annual Meeting. The company will also showcase research supported by its NMIBC research fe…

Allied Gaming & Entertainment Announces Special Meeting Proposal Focused on Capital Structure to Support M&A and Financing Plan

Allied Gaming & Entertainment Announces Special Meeting Proposal Focused on Capital Structure to Support M&A and Financing Plan

Allied Gaming & Entertainment Inc. announced a proposal for stockholders to approve a reverse stock split ranging from 1-for-2 to 1-for-25, aiming to optimize its capital structure and support potential future mergers, acquisitions, and financing initiatives. The company is responding proactively to a Nasdaq notice regarding minimum bid price requi…

Chicago Atlantic BDC, Inc. Announces Filing of a Shelf Registration Statement to Enhance Financial Flexibility and Support Portfolio Growth

Chicago Atlantic BDC, Inc. Announces Filing of a Shelf Registration Statement to Enhance Financial Flexibility and Support Portfolio Growth

Chicago Atlantic BDC, Inc., a NASDAQ-listed specialty finance business development company, announced it has filed a shelf registration statement with the SEC to issue up to $500 million of securities, providing greater flexibility to access capital markets and accelerate portfolio expansion. Proceeds may be used for investing, debt repayment, and …

Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results

Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results

Catalyst Pharmaceuticals announced its financial results for Q1 2026, highlighting a 5.6% year-over-year increase in total product revenue to $149.3 million, driven by strong sales growth of their key promoted products FIRDAPSE® and AGAMREE®. Net income rose to $63.7 million GAAP and $100.3 million non-GAAP, reflecting improved operating performanc…

Columbia Financial, Inc. Announces Commencement of Second-Step Conversion Offering; Receipt of Regulatory Approvals for the Conversion and the Acquisition of Northfield Bancorp, Inc.

Columbia Financial, Inc. Announces Commencement of Second-Step Conversion Offering; Receipt of Regulatory Approvals for the Conversion and the Acquisition of Northfield Bancorp, Inc.

Columbia Financial, Inc. announced the commencement of its second-step conversion offering of up to 192.6 million common shares to convert from a mutual holding company to a stock holding company. The company has received all necessary regulatory approvals and conditional approval to acquire Northfield Bancorp, Inc., which will close immediately fo…

Victoria’s Secret & Co. Files Supplement to Definitive Proxy Statement and Sends Letter to Shareholders Highlighting Outperformance

Victoria’s Secret & Co. Files Supplement to Definitive Proxy Statement and Sends Letter to Shareholders Highlighting Outperformance

Victoria’s Secret & Co. filed a supplement to its proxy statement and issued a letter to shareholders addressing a proxy contest launched by BBRC International and its Chairman Brett Blundy, opposing the re-election of two Board members. The Company highlights its strong operational and financial performance under CEO Hillary Super, including a 152…

Getty Images Reports First Quarter 2026 Results

Getty Images Reports First Quarter 2026 Results

Getty Images announced its first quarter 2026 financial results with a modest 1.1% revenue increase and a significant reduction in net loss compared to last year. Despite challenges in segments like Agency and microstock, the corporate subscription business grew, and the company maintained its full-year revenue and adjusted EBITDA guidance. The ong…

Oculis Reports Q1 2026 Financial Results and Provides Company Update

Oculis Reports Q1 2026 Financial Results and Provides Company Update

Oculis Holding AG reported strong Q1 2026 results highlighting significant progress across its late-stage ophthalmology pipeline. The company completed last patient visit in its pivotal Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema with topline data expected in June 2026, planning NDA submission by year-end. Its genotype-driven Licami…

Health Catalyst Reports First Quarter 2026 Results

Health Catalyst Reports First Quarter 2026 Results

Health Catalyst, a healthcare intelligence company, reported Q1 2026 financial results showing total revenue of $70.8 million, down 11% year-over-year, with adjusted EBITDA of $9.1 million, up 46%. The company undertook a strategic reset focusing on its technology opportunities, resulting in a significant goodwill impairment charge of $95.5 million…

MARA Announces First Quarter 2026 Results

MARA Announces First Quarter 2026 Results

MARA Holdings, Inc. announced its preliminary, unaudited financial results for the first quarter of 2026 and invited investors to a webcast and conference call to discuss the results. The company continues to focus on deploying digital energy technologies to optimize energy systems and reduce energy demands in computing applications.

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026

Roivant Sciences Ltd. announced it will report financial results for Q4 and fiscal year ended March 31, 2026, and provide an update on its biopharmaceutical pipeline on May 20, 2026. The company develops various drug candidates and utilizes nimble subsidiaries to advance their pipeline, aiming to improve patient outcomes.